Who invested in Neurophos?
Neurophos's investors include Gates Frontier, Alumni Ventures, Gaingels, M12 and DNX Ventures, and 11 more on record. Gates Frontier led its latest round.

United States · Series A startup
One round we have observed, with the 16 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 9 months ago
Follow Neurophos and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$110Mraised across 1 round since 2026, from 2 sources
Reported by Firms' own news pages and 1 otherSEC filing: $109M sold, first sale Nov 2025
Neurophos filed one raise, $109M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Neurophos's own website: 2 founders, 7 on the team.
AdvisersCarl RameyDoug Wightman
Neurophos's investors include Gates Frontier, Alumni Ventures, Gaingels, M12 and DNX Ventures, and 11 more on record. Gates Frontier led its latest round.
Neurophos has raised $110M across 1 round since 2026.
Neurophos's most recent round was a Series A of $110M in Jan 2026, led by Gates Frontier.
Its most recent round, $110M in Jan 2026, is also its largest on record.
Neurophos's first round on record, in Jan 2026, was backed by Gates Frontier, Alumni Ventures and Gaingels and 13 others.
Neurophos's latest named round is a Series A, in Jan 2026.
Neurophos is based in the United States.
Gates Frontier led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.